Join Now

Author Archives: Press Release

Why Antimicrobial Resistance Is Top of bioMérieux’s Diagnostic List

By Press Release | Published October 19, 2023

CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux

Posted in BioUtah News | Tagged | Comments Off on Why Antimicrobial Resistance Is Top of bioMérieux’s Diagnostic List

Arcutis Presents Positive Patient-Reported Outcome Data from the Pivotal ARRECTOR Phase 3 Trial in Scalp and Body Psoriasis at European Academy of Dermatology and Venereology (EADV) Congress

By Press Release | Published October 19, 2023

Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis

Posted in BioUtah News | Tagged | Comments Off on Arcutis Presents Positive Patient-Reported Outcome Data from the Pivotal ARRECTOR Phase 3 Trial in Scalp and Body Psoriasis at European Academy of Dermatology and Venereology (EADV) Congress

ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award

By Press Release | Published October 12, 2023

ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award

Posted in BioUtah News | Tagged | Comments Off on ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award

Merit Medical Launches Expanded Maestro® Microcatheter Line

By Press Release | Published October 12, 2023

New multipurpose microcatheter length complements Merit’s radial-first legacy

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Launches Expanded Maestro® Microcatheter Line

GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

By Press Release | Published October 12, 2023

GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.

Posted in BioUtah News | Tagged | Comments Off on GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

By Press Release | Published October 12, 2023

US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

Posted in BioUtah News | Tagged | Comments Off on US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

By Press Release | Published September 28, 2023

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

Posted in BioUtah News | Tagged | Comments Off on New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding

By Press Release | Published September 28, 2023

Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding

Posted in BioUtah News | Tagged | Comments Off on Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding

Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility

By Press Release | Published September 28, 2023

Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility

Posted in BioUtah News | Tagged | Comments Off on Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

By Press Release | Published September 28, 2023

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

Posted in BioUtah News | Tagged | Comments Off on Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

By Press Release | Published September 28, 2023

Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).

Posted in BioUtah News | Tagged | Comments Off on bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

By Press Release | Published September 21, 2023

Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies

Posted in BioUtah News | Comments Off on Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

A Special Thanks To Our Elite Members